Computational neuropsychiatry uses active inference to explain psychiatric symptoms as dysfunctional neuronal message passing and belief updating. While synaptopathies impair neuromodulatory precision weighting causing aberrant inference, disorders of brain function involve structural damage, challenging the free energy principle's application. Recognizing this distinction may enhance future neuropsychiatric models by integrating mechanisms beyond synaptic dysfunction.
Background
Active inference (AI) is a computational neuroscience framework that models brain function as Bayesian inference minimizing variational free energy. It explains perception and action as processes optimizing beliefs about the environment and future outcomes. Psychiatric disorders, often classified as synaptopathies, involve failures in synaptic function that disrupt precision weighting and belief updating. In contrast, neurological disorders like stroke or neurodegeneration involve structural brain damage, complicating the application of AI principles.
Data Highlights
The article primarily discusses theoretical frameworks and conceptual distinctions without presenting numerical data.
Key Findings
Active inference models brain function as minimizing variational free energy through belief updating and action selection.
Synaptopathies, including most psychiatric disorders, impair neuromodulatory precision weighting, leading to rigid or overly sensitive inferences.
Neuromodulators such as dopamine, noradrenaline, acetylcholine, and serotonin regulate precision weighting critical for inference and planning.
Disconnection syndromes involve structural white matter damage causing reduced functional integration, distinct from synaptopathies' functional dysconnection.
Distinguishing between disorders of inference (synaptopathies) and disorders of brain function (structural damage) is essential for refining computational neuropsychiatric models.
Future models should incorporate mechanisms beyond neuronal message passing to better explain neuropsychiatric symptoms.
Clinical Implications
Understanding the distinction between synaptopathies and structural brain disorders can guide targeted therapeutic strategies focusing on neuromodulatory systems in psychiatric conditions. Computational models incorporating both functional and structural aspects may improve diagnosis and treatment personalization. Clinicians should consider both synaptic dysfunction and brain network disconnection when evaluating neuropsychiatric symptoms.
Conclusion
Computational neuropsychiatry, grounded in active inference, offers a powerful framework for understanding psychiatric disorders as disorders of inference. Expanding models to include distinctions between synaptopathies and structural brain damage will enhance their explanatory and clinical utility.
Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.
